1. Home
  2. EVO vs EEX Comparison

EVO vs EEX Comparison

Compare EVO & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • EEX
  • Stock Information
  • Founded
  • EVO 1993
  • EEX 2013
  • Country
  • EVO Germany
  • EEX United States
  • Employees
  • EVO N/A
  • EEX N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • EEX Advertising
  • Sector
  • EVO Health Care
  • EEX Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • EEX Nasdaq
  • Market Cap
  • EVO 1.2B
  • EEX 1.0B
  • IPO Year
  • EVO 2021
  • EEX 2017
  • Fundamental
  • Price
  • EVO $3.48
  • EEX $5.03
  • Analyst Decision
  • EVO Buy
  • EEX Strong Buy
  • Analyst Count
  • EVO 2
  • EEX 2
  • Target Price
  • EVO $5.40
  • EEX $7.95
  • AVG Volume (30 Days)
  • EVO 52.1K
  • EEX 41.0K
  • Earning Date
  • EVO 11-05-2025
  • EEX 10-29-2025
  • Dividend Yield
  • EVO N/A
  • EEX 1.17%
  • EPS Growth
  • EVO N/A
  • EEX N/A
  • EPS
  • EVO N/A
  • EEX 0.04
  • Revenue
  • EVO $912,894,891.00
  • EEX $432,600,000.00
  • Revenue This Year
  • EVO $0.43
  • EEX $15.99
  • Revenue Next Year
  • EVO $9.72
  • EEX $7.56
  • P/E Ratio
  • EVO N/A
  • EEX $140.06
  • Revenue Growth
  • EVO N/A
  • EEX 9.96
  • 52 Week Low
  • EVO $2.84
  • EEX $3.22
  • 52 Week High
  • EVO $5.64
  • EEX $6.65
  • Technical
  • Relative Strength Index (RSI)
  • EVO 39.62
  • EEX 49.05
  • Support Level
  • EVO $3.36
  • EEX $4.81
  • Resistance Level
  • EVO $3.52
  • EEX $5.45
  • Average True Range (ATR)
  • EVO 0.08
  • EEX 0.22
  • MACD
  • EVO 0.00
  • EEX 0.01
  • Stochastic Oscillator
  • EVO 31.58
  • EEX 34.38

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.

Share on Social Networks: